• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌患者接受纳武利尤单抗治疗后发生急性动脉炎致主动脉破裂:一种罕见但严重的免疫相关不良事件。

Aortic rupture following acute aortitis in a patient with head and neck carcinoma treated with nivolumab: a rare but severe immune-related adverse event.

机构信息

Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, 1-757, Asahimachi-dori, Chuo-ku, Niigata City, Niigata, 950-8510, Japan.

出版信息

Eur Arch Otorhinolaryngol. 2024 Apr;281(4):2037-2040. doi: 10.1007/s00405-024-08495-2. Epub 2024 Feb 3.

DOI:10.1007/s00405-024-08495-2
PMID:38308762
Abstract

INTRODUCTION

Immune-related adverse events (irAEs) due to immune checkpoint inhibitors may lead to discontinuation and treatment-related death. Acute aortitis is a rare but severe irAE.

CASE PRESENTATION

A 67-year-old man with recurrent lower gingival carcinoma received nivolumab therapy. Twenty-three months later, he experienced chest compression, which resulted in syncope. Following a whole-body computed tomography (CT) scanning, which revealed diffuse thickening of the aorta, and systemic assessments of the causes of aortitis, he was diagnosed with acute aortitis due to irAE. Nivolumab discontinuation and oral steroids improved CT findings. However, 11 months after nivolumab discontinuation, he developed an aortic aneurysmal rupture. Endovascular aortic repair rescued him. A durable anti-cancer response was still observed 4 months after the aortic rupture.

CONCLUSION

Although severe irAE, such as acute aortitis, occurred, the patient may still achieve a durable response. A broad examination and prompt treatment of irAE can help improve the patient's survival.

摘要

简介

免疫检查点抑制剂引起的免疫相关不良反应(irAEs)可能导致停药和治疗相关死亡。急性主动脉炎是一种罕见但严重的 irAE。

病例介绍

一名 67 岁男性,患有复发性下牙龈癌,接受了nivolumab 治疗。23 个月后,他出现胸痛,导致晕厥。全身 CT 扫描显示主动脉弥漫性增厚,系统性评估主动脉炎的病因后,他被诊断为免疫检查点抑制剂引起的急性主动脉炎。停用 nivolumab 和口服类固醇改善了 CT 发现。然而,在停用 nivolumab 11 个月后,他发生了主动脉瘤破裂。血管内主动脉修复挽救了他。主动脉破裂后 4 个月仍观察到持久的抗肿瘤反应。

结论

尽管发生了严重的 irAE,如急性主动脉炎,但患者仍可能获得持久的反应。广泛的 irAE 检查和及时治疗有助于提高患者的生存率。

相似文献

1
Aortic rupture following acute aortitis in a patient with head and neck carcinoma treated with nivolumab: a rare but severe immune-related adverse event.头颈部癌患者接受纳武利尤单抗治疗后发生急性动脉炎致主动脉破裂:一种罕见但严重的免疫相关不良事件。
Eur Arch Otorhinolaryngol. 2024 Apr;281(4):2037-2040. doi: 10.1007/s00405-024-08495-2. Epub 2024 Feb 3.
2
Nivolumab-Induced Periaortitis Demonstrated by FDG PET/CT.纳武利尤单抗诱导的腹主动脉周炎的 FDG PET/CT 表现。
Clin Nucl Med. 2020 Nov;45(11):910-912. doi: 10.1097/RLU.0000000000003215.
3
Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: Prediction of immune-related adverse events and favorable outcome.尼伏单抗治疗复发性/转移性头颈部鳞状细胞癌患者中嗜酸性粒细胞的作用:预测免疫相关不良事件和良好结局。
Cancer Med. 2023 Nov;12(22):20810-20820. doi: 10.1002/cam4.6648. Epub 2023 Oct 30.
4
Endovascular Management of Concomitant Thoracic and Abdominal Aortic Ruptures Resulting from Brucellosis Aortitis.布鲁氏菌性主动脉炎所致胸主动脉和腹主动脉同时破裂的血管内治疗
Ann Vasc Surg. 2017 Jan;38:190.e1-190.e4. doi: 10.1016/j.avsg.2016.08.007. Epub 2016 Aug 20.
5
Endovascular repair of aortic rupture due to Brucella aortitis.布鲁氏菌性主动脉炎所致主动脉破裂的血管内修复术
Vasa. 2011 Mar;40(2):150-6. doi: 10.1024/0301-1526/a000086.
6
An immunosuppressed man with an aortic rupture secondary to Salmonella aortitis successfully treated with endovascular aortic repair.一名因沙门氏菌性主动脉炎继发主动脉破裂的免疫抑制患者通过血管内主动脉修复术成功治愈。
Ann Vasc Surg. 2015 May;29(4):839.e5-8. doi: 10.1016/j.avsg.2014.11.019. Epub 2015 Feb 23.
7
Nivolumab-related tracheobronchial chondritis: Extremely rare manifestation of an immune-related adverse effect.纳武利尤单抗相关的气管支气管软骨炎:免疫相关不良反应的极其罕见表现。
Head Neck. 2020 Nov;42(11):E43-E48. doi: 10.1002/hed.26456. Epub 2020 Sep 5.
8
Durable disease control and refractory bullous pemphigoid after immune checkpoint inhibitor discontinuation in metastatic renal cell carcinoma: A case report.转移性肾细胞癌患者停用免疫检查点抑制剂后疾病持久控制且并发难治性大疱性类天疱疮:一例报告。
Front Immunol. 2022 Sep 16;13:984132. doi: 10.3389/fimmu.2022.984132. eCollection 2022.
9
Recurrent rupture of an infected aortic arch.感染性主动脉弓反复破裂。
Tex Heart Inst J. 2010;37(5):591-3.
10
Impending rupture of nonaneurysmal bacterial aortitis: CT diagnosis.非动脉瘤性细菌性主动脉炎的即将破裂:CT诊断
J Comput Assist Tomogr. 1990 Nov-Dec;14(6):950-3. doi: 10.1097/00004728-199011000-00015.

引用本文的文献

1
Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.癌症免疫治疗中肠道微生物群的应用:机制、挑战及个性化医疗途径——一项系统综述
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.
2
Drug-associated abdominal aortitis and retroperitoneal fibrosis after treatment with nivolumab.使用纳武单抗治疗后出现的药物相关性腹主动脉炎和腹膜后纤维化。
J Vasc Surg Cases Innov Tech. 2025 Apr 28;11(4):101824. doi: 10.1016/j.jvscit.2025.101824. eCollection 2025 Aug.

本文引用的文献

1
A Case Report of Immune Checkpoint Inhibitor-Induced Aortitis Treated with Tocilizumab.一例用托珠单抗治疗免疫检查点抑制剂诱发的主动脉炎的病例报告
Case Reports Immunol. 2022 Oct 12;2022:7971169. doi: 10.1155/2022/7971169. eCollection 2022.
2
A Rare Case of Large-Vessel Vasculitis following Checkpoint Inhibitor Therapy and Pegfilgrastim.一例罕见的在检查点抑制剂治疗和培非格司亭治疗后发生的大血管血管炎病例。
Case Rep Oncol Med. 2022 Feb 23;2022:7295305. doi: 10.1155/2022/7295305. eCollection 2022.
3
Inflammatory Thoracic Aortic Aneurysm in a Patient with Advanced Lung Adenocarcinoma Treated with Pembrolizumab.
接受派姆单抗治疗的晚期肺腺癌患者的炎症性胸主动脉瘤。
Intern Med. 2022 Aug 1;61(15):2339-2341. doi: 10.2169/internalmedicine.8688-21. Epub 2022 Jan 13.
4
Clinical outcome in recurrent and/or metastatic head and neck cancer patients after discontinuation of nivolumab monotherapy due to immune-related adverse events.由于免疫相关不良反应而停用纳武利尤单抗单药治疗后复发和/或转移性头颈部癌症患者的临床结局。
Acta Otolaryngol. 2020 Dec;140(12):1043-1048. doi: 10.1080/00016489.2020.1807601. Epub 2020 Aug 18.
5
Immune checkpoint inhibitor induced large vessel vasculitis.免疫检查点抑制剂引起的大血管血管炎。
BMJ Case Rep. 2020 May 18;13(5):e233496. doi: 10.1136/bcr-2019-233496.
6
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.帕博利珠单抗单药或联合化疗对比西妥昔单抗联合化疗用于治疗复发性或转移性头颈部鳞状细胞癌(KEYNOTE-048):一项随机、开放标签、III 期研究。
Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.
7
Discontinuation due to immune-related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non-small cell lung cancer.由于免疫相关不良事件而停药是预测非小细胞肺癌患者免疫检查点抑制剂疗效的一个可能因素。
Thorac Cancer. 2019 Sep;10(9):1798-1804. doi: 10.1111/1759-7714.13149. Epub 2019 Jul 22.
8
Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.纳武利尤单抗治疗转移性肾细胞癌患者的免疫相关不良事件与预后的相关性。
Urol Oncol. 2019 Jun;37(6):355.e21-355.e29. doi: 10.1016/j.urolonc.2019.03.003. Epub 2019 Mar 29.
9
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.免疫相关不良事件对纳武利尤单抗治疗的晚期非小细胞肺癌患者生存的影响:多机构分析的长期结果。
J Cancer Res Clin Oncol. 2019 Feb;145(2):479-485. doi: 10.1007/s00432-018-2805-3. Epub 2018 Dec 1.
10
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.免疫检查点抑制剂相关的心血管毒性:一项观察性、回顾性、药物警戒研究。
Lancet Oncol. 2018 Dec;19(12):1579-1589. doi: 10.1016/S1470-2045(18)30608-9. Epub 2018 Nov 12.